Develops therapies that target shared biology across multiple rare diseases using best-in-class antibodies to reduce treatment burden.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Star Therapeutics discovers and develops novel antibody therapies to address serious diseases with unmet needs, especially in hematology and immunology. It employs a “pipeline-in-a-product” strategy, whereby a single therapeutic program may target multiple diseases that share underlying biology. Its lead program, VGA039, is a first-in-class antibody for bleeding disorders (initially von Willebrand disease) being developed for monthly subcutaneous dosing.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Star Therapeutics Management Team
Investors
Catalio Capital Management
OrbiMed
New Leaf Venture Partners
Sanofi Ventures
GordonMD Global Investments
Viking Global Investors
Blue Owl Capital
Janus Henderson
RA Capital Management
Westlake Village BioPartners
Redmile Group
Cormorant Asset Management
Sofinnova Investments
Soleus Capital Management
Frazier Life Sciences Management
Qatar Investment Authority (QIA)
NYBC Ventures
Agent Capital
Star Therapeutics Valuations & Financials
View real-time NPM data on Star Therapeutics stock including daily Star Therapeutics stock price estimates, valuation history, and historical share price information. Access Star Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Star Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Star Therapeutics? Get in touch to learn more.
Similar Companies
like Star Therapeutics
FAQ
We have answers
Star Therapeutics stock does not trade on public stock exchanges. Star Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Star Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Star Therapeutics Stock does not trade on public stock exchanges. In order to sell Star Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Star Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Star Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Star Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Star Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Star Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Star Therapeutics is a private company and has not had an IPO. There is currently no Star Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Star Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
